SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lincoln Pharmaceuticals informs about newspaper advertisement

26 Aug 2023 Evaluate

Lincoln Pharmaceuticals has informed that it enclosed copies of published newspaper advertisement with respect to compliance with general circular No. 10/2022 dated December 28, 2022 issued by Ministry of Corporate Affairs, with respect to 29th Annual General Meeting of the Company scheduled to be held on Saturday, September 30, 2023 at 11:00 am (IST) through Video Conferencing / Other Audio-Visual Means. The said advertisement was published in the newspapers: The Indian Express, Ahmedabad Edition - In English and Financial Express, Ahmedabad Edition - In Gujarati (Vernacular). 

The above information is a part of company’s filings submitted to BSE.

Lincoln Pharma Share Price

667.75 -33.00 (-4.71%)
12-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1845.90
Dr. Reddys Lab 1270.10
Cipla 1292.00
Zydus Lifesciences 930.75
Lupin 2246.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×